Plasma prostaglandin F2αand plasma 13,14-dihydro-15-keto-prostaglandin F2αlevels in women during induction of labor with i. v. infusion of prostaglandin F2αin relation to uterine contractions

Publisher Website
Google Scholar
Abstract
The concentrations of plasma PGF2.alpha. and its main metabolite, 13,14-dihydro-15-keto-PGF2.alpha. (PGFM) were measured in serial samples of blood collected in 10 pregnant women at term who were given i.v. infusions of low doses of PGF2.alpha. for induction of labor. Six other women served as controls and were given saline infusions. Uterine contractions began with a mean latency of 62 min in the PGF2.alpha. infused women, in controls uterine activity remained unchanged. Plasma PGFM levels had increased significantly 30 min after PGF2.alpha. infusion began, rising thereafter in a dose dependent manner. Plasma PGF2.alpha. also rose reaching a steady state at 2 h. No significant changes were observed in the controls. The 6-h infusion resulted in delivery in 5 of the 10 women, in the 5 others the cervical scores increased only by 1.25 points on the average and further treatment was needed to achieve delivery, although prostanoid levels rose to similar levels in all. The data show that when uterine contractions are induced by systemic PGF2.alpha., the levels of PGFM are significantly raised. In spontaneous labor uterine contractions begin long before plasma PGFM rises. Thus, if endogenous PGF2.alpha. generation is involved in the initiation of uterine contractions during spontaneous labor, it must be synthetized in the myometrium at quantities too low to raise the levels of circulating PGFM.